Insider Selling: Thomas Leonard Sells 1,250 Shares of CareFusion Corp. Stock (CFN)
CareFusion Corp. (NYSE:CFN) Insider Thomas Leonard sold 1,250 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $36.99, for a total transaction of $46,237.50. Following the completion of the sale, the insider now directly owns 63,549 shares in the company, valued at approximately $2,350,678. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
CareFusion Corp. (NYSE:CFN) traded up 0.24% on Friday, hitting $37.51. The stock had a trading volume of 1,057,905 shares. CareFusion Corp. has a 52-week low of $26.00 and a 52-week high of $39.38. The stock has a 50-day moving average of $36.74 and a 200-day moving average of $36.26. The company has a market cap of $8.041 billion and a P/E ratio of 21.73.
CareFusion Corp. (NYSE:CFN) last released its earnings data on Thursday, August 8th. The company reported $0.55 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.56 by $0.01. The company had revenue of $903.00 million for the quarter, compared to the consensus estimate of $918.25 million. During the same quarter last year, the company posted $0.51 earnings per share. CareFusion Corp.’s revenue was down 6.0% compared to the same quarter last year. On average, analysts predict that CareFusion Corp. will post $2.34 earnings per share for the current fiscal year.
CFN has been the subject of a number of recent research reports. Analysts at Citigroup Inc. reiterated a “hold” rating on shares of CareFusion Corp. (NYSE:CFN) in a research note to investors on Thursday, September 26th. They now have a $42.00 price target on the stock. Separately, analysts at B. Riley raised their price target on shares of CareFusion Corp. (NYSE:CFN) to $37.00 in a research note to investors on Thursday, September 26th. They now have a “neutral” rating on the stock. Finally, analysts at Stifel Nicolaus reiterated a “buy” rating on shares of CareFusion Corp. (NYSE:CFN) in a research note to investors on Thursday, August 29th. They now have a $42.00 price target on the stock. Seven research analysts have rated the stock with a hold rating and five have given a buy rating to the company. CareFusion Corp. has an average rating of “Hold” and a consensus price target of $38.50.
CareFusion Corporation (NYSE:CFN) is a global medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.